Physician

Fridolin Hoesly, M.D.

According to 2025 Medicare claims, Fridolin Hoesly, M.D. (NPI: 1285860288) practices dermatology in the Bend, OR market, with the plurality of this provider's patient population coming from Deschutes, OR. This provider's primary affiliated billing organization is MOUNTAIN WEST DERM - BLACKHART PLLC (NPI: 1447764741; TIN: 813253496) and primary practice location at 97701-8738.

Hoesly's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,892 traditional Medicare patients, billed 16,866 HCPCS/CPT codes, and received $586,185 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 1,224 prescription claims across 568 beneficiaries totaling $188,983 in drug costs, led by Taltz Autoinjector (Ixekizumab). Open Payments data shows 21 records totaling $574. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $72,879 to $188,983. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$293K$586K2015 Medicare payment: $363,512 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $424,491 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $418,419 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $460,541 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $516,397 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $466,720 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $435,826 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $459,991 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $514,047 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $586,185 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,23310,062$363,512
20161,60911,609$424,491
20171,67811,020$418,419
20181,63517,929$460,541
20191,88518,861$516,397
20201,90518,114$466,720
20211,36418,287$435,826
20221,61617,231$459,991
20231,78417,205$514,047
20241,89216,866$586,185

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$99K$198K2015 Drug cost: $72,879 (USD; Tot_Drug_Cst)2016 Drug cost: $65,363 (USD; Tot_Drug_Cst)2017 Drug cost: $120,015 (USD; Tot_Drug_Cst)2018 Drug cost: $182,977 (USD; Tot_Drug_Cst)2019 Drug cost: $131,731 (USD; Tot_Drug_Cst)2020 Drug cost: $76,880 (USD; Tot_Drug_Cst)2021 Drug cost: $158,363 (USD; Tot_Drug_Cst)2022 Drug cost: $197,872 (USD; Tot_Drug_Cst)2023 Drug cost: $194,416 (USD; Tot_Drug_Cst)2024 Drug cost: $188,983 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015445925$72,879
2016466916$65,363
20174881,003$120,015
20185591,200$182,977
20195881,187$131,731
20205501,077$76,880
2021472995$158,363
2022489963$197,872
20235111,123$194,416
20245681,224$188,983

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth562695$63
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,3131,926$57
88305Pathology examination of tissue using a microscope, intermediate complexity9381,733$41
17000Destruction of precancer skin growth, 1 growth9921,432$35
17003Destruction of precancer skin growth, 2-14 growths8095,777$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Taltz AutoinjectorIxekizumab11308$74,620
Dupixent PenDupilumab20560$72,246
Clobetasol PropionateClobetasol Propionate912,350$5,109
KetoconazoleKetoconazole1674,918$4,309
FluorouracilFluorouracil661,781$4,251

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.21$574ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Fridolin Hoesly, M.D.?

Tedicare shows public-source Medicare data for Fridolin Hoesly, M.D. (NPI 1285860288), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Fridolin Hoesly, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Fridolin Hoesly, M.D.?

Fridolin Hoesly, M.D. is linked to MOUNTAIN WEST DERM - BLACKHART PLLC (billing NPI 1447764741) in the available physician profile data.

Does Fridolin Hoesly, M.D. have Open Payments data?

Fridolin Hoesly, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.